AEZS - Æterna Zentaris Inc. - Page 6

Looks like we corrected some recently and stablized the last few trading days. Though battered hard by stormy market conditions this held up well. Barring any catastrophies, I expect us to make a solid attempt at getting to that upper trendline again. Support fairly solid in the $1.60 range and I want to see a steady increase in volume to get there, though I wouldn't be surprised on those early morning pops for a quick flip and opportunities for a re-entry.

For the Monthly, close to testing the 50MA again (currenlty at $2.35). Last week upper wick hit 2.19.
For the Weekly, close to testing the 200MA again (currently at $2.09). Last week upper wick hit 2.19.
For the Daily, positive 50/200 cross on May 17th and currently trading above those ma's. Today's upper wick touched the 9ema so I'll definitely be watching Monday's action to see if we can get over this.



From May 10th -

Press Release Source: AETERNA ZENTARIS INC.
On Friday May 21, 2010, 8:35 am EDT
QUÉBEC CITY, May 21 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), (the "Company") a late-stage drug development company specialized in oncology and endocrine therapy, today announced that data on two of its lead anticancer compounds, perifosine and AEZS-108, will be presented at the upcoming Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held June 4 through 8, 2010 at McCormick Place in Chicago.

Rest of PR:
Aeterna Zentaris: Data on Lead Anticancer Compounds Perifosine and AEZS-108 to be Presented at Upcoming ASCO Annual Meeting

Well...wasn't as great as I hoped. There is always tomorrow...

.....had a nice last hour of trading to finish up 11.25%

Cheers

Dillution....

http://www.prnewswire.com/news-relea...-96434514.html

think itll climb back to pre-dillution levels relatively quickly? seems like its off to a good start.

AEZS showing some signs of life after last month's dilution. Looks to me like the stage 4 markdown is over, and we're possibly well into an accumulation phase. Looking to get in under 1.15, it is pumped today by microstockprofit so take the volume with a grain of salt and try to hold out for 1.10 or better, but I like this stock's chances over the next month.

Hopefully you were able to get some Rando!! Not in this time, but looks like the run has started. No resistance til 1.60's IMO.

It's pumped by seekingalpha.
I just shorted it Will cover at 1.16 on Monday

actually shot up into resist at 1.40 and pulled back...and i dont see any real resist around 1.60 tho...1.20 1.40 and 1.80 is pretty clear tho...

not the typical way a run starts...a lil to abrupt for me to be thinking anything sustainable...

Started a position, loooks like it might blow up soon

Who is waiting on this to hit the 50ma to load the boat? November could be an interesting month.



That event occurs the 16-19th.

Then they announced a few days ago this.

http://finance.yahoo.com/news/Aetern....html?x=0&.v=2

"Aeterna Zentaris to Make Poster and Oral Presentations on Highly Selective Erk Inhibitor Compound, AEZS-131, at Major Cancer Conference in Boston"

And this is the 2nd-4th.

I know it can move. The seeking alpha pump proved that. Just have to figure out now what is going to move it

IMO the news that is guaranteed to move this stock is Kerx and Perifosine. AEZS-130 is a distant second. Perifosine approval and revenue from it alone would probably price this 2.50+. But those catalysts won't come until next year. KERX's other leading candidate Zerenex is approaching a huge catalyst in December and I think it will rise leading in to that. Maybe AEZS catches some of the extra momo?

Edging closer....

Loaded up at 1.31. I've been waiting on this for a couple weeks.

I'm not looking for anything spectacular but I think this has a chance to break 1.50 early next week. I was watching for any large buys that would signal a bounce off the 50ma similar to the day before it ran to 1.40. Here's what they will present and most likely PR about early next week.


"Aeterna Zentaris Inc. (NASDAQ:AEZS - News), ("the Company") today announced that it will present a poster on Phase 2 results for AEZS-108 in advanced endometrial cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics to be held at the Berlin Estrel Hotel and Convention Centre in Berlin, Germany November 16 through 19, 2010.

"QUÉBEC CITY, Nov. 11 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:AEZS - News) today announced that its Senior Vice President and Chief Financial Officer, Dennis Turpin, CA, will make a corporate presentation on Wednesday, November 17, 2010, from 9:55 a.m. to 10:15 a.m. (eastern time), at the Dundee Capital Markets Emerging Growth Conference, to be held at the St. Andrew's Club in Toronto, Canada."

Started the day out strong. 1.35x1.36 right now.

Upgraded by Versant to a target price of $4 from $2.50